Overview
Cigarette smoking continues to be one of the most prevalent causes of preventable morbidity and mortality in the United States (1,2).In the United States, an estimated 47 million adults smoke, and over 400,000 deaths/yr are attributable to smoking (3,4).Tobacco use is causally linked to diseases such as cancer, heart disease, stroke, and chronic obstructive pulmonary disease (5)and is responsible for over $50 billion in annual healthcare expenditures (6). Moreover, Environmental Tobacco Smoke (ETS) or “second hand smoke” has been strongly associated with respiratory illness in children and with both cancer and heart disease in adults living with smokers (7). The prevalence of smoking decreased dramatically in the United States between 1950 and 1980 (8),coinciding with the release of a series of reports from the U.S. Surgeon General regarding the effects of tobacco smoking on health. However, this trend has not continued. Today, one quarter of all adults living in this country smoke (9),and the rate of smoking among high school students increased throughout the 1990s (10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
US Dept of Health and Human Services. Cigarette smoking among adults-United States 1994. MMWR 1996; 45: 588 – 590.
Peto R, Lopez AD, Boreham J, Thumn M, Heath C. Mortality from smoking in developing countries: 1950–2000. Oxford University Press, Oxford, 1994.
CDC. Smoking-attributable mortality and years of potential life lost United States 1984. MMWR 1997; 46: 444 – 451.
Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 2000; 284: 706 – 712.
US Dept of Health and Human Services. Health Benefits of Smoking Cessation. Report of the US Surgeon General. Washington, DC: US GPO DHHS Pub. No. (CDC) 90 – 8416. 1990.
Miller LS, Zhang X, Rice DP, Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep 1998; 113: 447 – 458.
Ducatman AM, McLellan RK. Epidemiologic basis for an occupational and environmental policy on environmental tobacco smoke. J Occup Environ Med 2000; 42: 1137 – 1141.
Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev 1995; 17: 48 – 65.
CDC. Health objectives for the nation. Cigarette smoking among adults-United States, 1997. MMWR 1999; 48: 993 – 996.
CDC. Reducing tobacco use: A report of the Surgeon General Executive Summary. MMWR 2000; 49: 706 – 712.
Anderson RN, Kochanek KD, Murphy SL. Report of final mortality statistics, 1995. Monthly Vital Statistics Report 1997; 45 (Suppl. 2): 1 – 80.
CDC. Mortality patterns United States, 1997. MMWR 1999; 48: 664 – 668.
Kochanek KD, Smith BL, Anderson RN. Deaths: preliminary data for 1999. Natl Vital Statistics Reports 2001; 49: 1 – 48.
USDHHS. Office of the Assistant Secretary for Health and Surgeon General, Office on smoking and Health: The health consequences of involuntary smoking: A report of the Surgeon General, 1986. Rockville, MD. US Department of Health and Human Services, Public Health Service Centers for Disease Control, Center for Health Promotion and Education Office on Smoking and Health. For sale by the Superintendent of Documents, US Government Printing Office, 1986.
Taylor BV, Oudit GY, Kalman PG, et al. Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system. Can J Cardiol 1998; 13: 1129.
Villablanca, AC, McDonald JM, Rutledge JC. Smoking and cardiovascular disease. Clin Chest Med 2000; 21: 159 – 172.
Houston-Miller N, Smith PM, DeBusk RF, Sobel DS, Taylor CB. Smoking cessation in hospitalized patients: results of a randomized trial. Arch Intern Med 1997; 157: 409 – 415.
Orleans CT, Ockene JK. Routine hospital-based quit-smoking treatment for the post myocardial infarction patient: an idea whose time has come. JAm Coll Cardiol 1993; 22: 1703 – 1705.
Rigotti N, Arnsten JH, McKool KM, Wood-Reid KM, Pasternak RC, Singer DE. Efficacy of a smoking cessation program for hospital patients. Arch Intern Med 1997; 157: 2653 – 2660.
Glasgow RE, Stevens VJ, Vogt TM, Mullooly JP, Lichtenstein E. Changes in smoking associated with hospitalization: quit rates, predictive variables, and intervention implications. Am J Health Promo 1991; 6: 24 – 29.
Rigotti N, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery. Ann Intern Med 1994; 120: 287 – 293.
Stevens VJ, Glasgow RE, Hollis JF, Lichtenstein E, Vogt TM. A smoking-cessation intervention for hospital patients. Med Care 1993; 31: 65 – 72.
Ockene JK, Emmons KM, Mermelstein RJ, et al. Relapse and maintenance issues for smoking cessation. Health Psychol 2000; 19 (Suppl. 1): 17 – 31.
Goldstein MG, Niaura R, Willey-Lessne C, et al. Physicians counseling smokers: a population-based survey of patients’ perceptions of health care provider delivered smoking cessation interventions. Arch Intern Med 1997; 157: 1313 – 1319.
Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA 1998; 279: 604 – 608.
Cohen SJ, Katz BP, Drook CA, Smith DM. Encouraging primary care physicians to help smokers quit. A randomized, controlled trial. Ann Intern Med 1989; 110: 648 – 652.
Cummings SR, Stein MJ, Hansen B, et al. Smoking counseling and preventive medicine. A survey of internists in private practices and health maintenance organizations. Arch Intern Med 1989; 149: 345 – 349.
Lewis CE, Clancy C, Leake B, Schwartz JS. The counseling practices of internists. Ann Intern Med 1991; 114: 54 – 58.
Strecher VJ, O’Malley MS, Villagra VG, et al. Can residents be trained to counsel patients about quitting smoking? Results from a randomized trial. J Gen Intern Med 1991; 6: 9 – 17.
Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical practice guideline. US Department of Health and Human Services, Public Health Service, Rockville, MD, June 2000.
Ockene JK, Kristeller J, Pbert L, et al. The physician-delivered smoking intervention projects: can short-term interventions produce long-term effects for a general outpatient population? Health Psychol 1994; 13: 278 – 281.
Daughton D, Susman J, Sitorius M, et al. Transdermal nicotine therapy and primary care: importance of counseling demographic and participant selection factors on 1-year quit rates. Arch Fam Med 1998; 7: 425 – 430.
Ellerbeck EF, Ahluwalia JS, Jolicoeur DG, Gladden J, Mosier MC. Direct observation of smoking cessation activities in primary care practice. JFam Pract 2000; 50: 688 – 693.
Jackson G, Bobak A, Chorlton I, et al. Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract 2001; 55: 385 – 392.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390 – 395.
Sciamanna CN, Hoch JS, Duke GC, Fogie MN, Ford DE. Comparison of five measures of motivation to quit smoking among a sample of hospitalized smokers. J Gen Intern Med 2000; 15: 16 – 23.
Leischow S, Muramoto ML, Cook G, Merikle E, Castellini S, Otte PS. OTC nicotine patches: effectiveness alone and with brief physician intervention. Am J Health Behavior 1999; 23: 61 – 69.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br JAddiction 1991; 86: 1119 – 1127.
Rundmo T, Smedslund G, Gotestam KG. Motivation for smoking cessation among the Norwegian public. Addict Behav 1997; 22: 377 – 386.
Colby SM, Barnett NP, Monti PM, et al. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. J Consult Clin Psychol 1998; 66: 574 – 578.
Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991: 12: 727 – 735.
Sachs DPL, Benowitz NL, Bostron AG, et al. Percent serum replacement and success of nicotine patch therapy. Am Rev Respir Crit Care Med 1995; 151: A688
Dale LC, Hurt RD, Offord KP, et al. High dose nicotine patch therapy: percentage of replacement and smoking cessation. JAMA 1995; 274: 1353 – 1358.
Kornitzer M, Boutsen M, Drammaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prey Med 1995; 24: 41 – 47.
Cepeda-Benito, A. Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 1993; 61: 822 – 830.
Henningfield JE. Nicotine medications for smoking cessation. N Engl JMed 1995; 333: 1196 – 1203.
Jorenby DE, Leischow S, Nides M, et al. A controlled trial so sustained-release bupropion, a nicotine patch or both for smoking cessation. N Engl JMed 1999; 340: 685 – 691.
Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683 – 690.
Hughes J, Goldstein MG. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281; 72 – 76.
Prochazka AV. New developments in smoking cessation. Chest 2000; 117 (Suppl. 1): 1695 – 1755.
Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993; 153: 1881 – 1890.
Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. NEngl JMed 1984; 319: 1318 – 1330.
Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. JAm Coll Cardiol 1993; 22: 1159 – 1167.
Joseph AM, Westman EC. Transdermal nicotine therapy for older medically ill patients: a pilot study. J Gen Intern Med 1995; 10 (Suppl.): 101.
Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3133 – 3138.
Jackson, M. Cerebral arterial narrowing with nicotine patch. Lancet. 1993; 342: 236 – 237.
Warner JG Jr, Little WC. Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med 1994; 120: 695.
58. Arnaot MR. Treating heart disease: nicotine patches may not be safe. Br Med J 1995;310:663 – 664.
Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. JAm Coll Cardiol 1997; 29: 1422 – 1431.
Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792 – 1798.
Mahmarian JJ, Moye LA, Nasser GA et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia JAm Coll Cardiol 1997; 30: 125 – 130.
Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989 – 995.
Brandon TH, Tiffany ST, Obremski K, Baker TB. Postcessation cigarette use: the process of relapse. Addictive Behaviors 1990; 15: 105 – 114.
Carroll KM. Relapse prevention as a psychosocial treatment: a review of controlled clinical trials. Exp Clin Psychopharmacol 1996; 4: 46 – 54.
Bock BC, Becker B, Partridge R, Fisher S, Monteiro R, Spencer J. Physician intervention and patient attitudes among smokers with acute respiratory illness in the emergency department. Prey Med 2001; 32: 175 – 181.
Emmons K, Goldstein MG. Smokers who are hospitalized: a window of opportunity for cessation interventions. Prey Med 1992; 21: 262 – 269.
Leistikow BN. The human and financial costs of smoking. Clin Chest Med 2000; 21: 189 – 197.
Jaen CR, Stange KC, Tumiel LM, Tumiel LM, Nutting P. Missed opportunities for prevention: smoking cessation counseling and the competing demands of practice. JFam Pract 1997; 45: 348 – 354.
Bartecchi CE, MacKenzie MD, Schier W. The human costs of tobacco use. N Engl J Med 1994; 330: 907 – 912.
Gourlay SG, Forbes A, Marriner T, et al. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ 1995; 311: 363 – 366.
Miller W, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, 1991.
Perkins K. Maintaining smoking abstinence after myocardial infarction. JSubstAbuse 1988; 1: 91 – 107.
Wei H, Young D. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. Br JAddic 1988; 83: 1221 – 1226.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Bock, B.C., Becker, B. (2003). Smoking Cessation. In: Cannon, C.P. (eds) Management of Acute Coronary Syndromes. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-351-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-59259-351-4_26
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-309-1
Online ISBN: 978-1-59259-351-4
eBook Packages: Springer Book Archive